Plain-English translation of NCT07495631 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new treatment approach for a serious blood cancer called acute lymphoblastic leukemia in adults. The study combines traditional chemotherapy with a newer medication called and optional immunotherapy drugs (like or CAR-T cell therapy) to see if this combination works better than older treatments. The approach is inspired by successful treatments that have worked well in children and young adults with this disease.
Adults with this type of leukemia have historically had worse outcomes than children with the same disease. Researchers want to see if combining a pediatric-inspired chemotherapy approach with and immunotherapy can improve survival rates and help more patients recover.
You likely qualify if…
You likely don't qualify if…
You would receive multiple phases of treatment over many months. First comes an intensive induction phase with chemotherapy and (given intravenously or by mouth), which typically lasts several weeks. If you respond well, you move to with additional chemotherapy drugs, and you may be offered optional immunotherapy drugs like or CAR-T cell therapy. Throughout, you'll have regular blood tests and hospital visits. After intensive treatment, you'll receive (monthly or every 3 months) for an extended period. Some patients may also be candidates for a stem cell transplant depending on their response.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
China